Vertex snags 1st US FDA 'breakthrough therapy' designations
This article was originally published in Scrip
Executive Summary
For the past couple of months, the US FDA has been keeping under wraps the identity of the company that won the first breakthrough therapy designation, a status aimed at speeding up the development and review processes for medicines intended to treat serious or life-threatening diseases.